During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade also check out my Top 2011 Stock Gainers, Stocks to Buy 2012.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow -0.31% to 13168. S&P -0.12% to 1404. Nasdaq -0.24% to 3014.
Treasurys: 30-year +0.03%. 10-yr -0.01%. 5-yr +0.03%.
Commodities: Crude -0.11% to $92.77. Gold -0.73% to $1608.85.
Currencies: Euro +0.38% vs. dollar. Yen +0.12%. Pound +0.03%
After Hours News:
IAMGOLD Corporation (IAG): Q2 EPS of $0.20 in-line. Revenue of $411M (+19% Y/Y) beats by $14M
Array BioPharma (ARRY): FQ4 beats on a 9% Y/Y jump in total revenue. Net losses were pared significantly from the prior year period, as its top line was boosted by a jump in sales and its bottom line benefited from milestone payments from AMGN. Shares +6.6% AH
Groupon (GRPN): Q2 EPS of $0.08 beats by $0.05. Revenue of $568.3M (+45% Y/Y) misses by $4.8M. Expects Q3 revenue of $580M-$620M, in-line with $604.5M consensus. Expects Q3 operating income of $15M-$35M, below Q2's $46.5M. Shares -7.5% AH
Monster Beverage (MNST) +0.9% AH after announcing a new $250M stock buyback program. That boosts the energy drink maker's total available authorization to $500M, good for repurchasing 5.3% of shares at current levels. Monster fell last week on an earnings miss and AG probe
Summer Infant (SUMR): Q2 EPS of -$0.02 misses by $0.10. Revenue of $61.7M (+1.1% Y/Y) misses by $2M. Shares -19.2% AH.
Envivio (ENVI) -39.5% AH after warning it expects FQ2 revenue of $10M-$11M, well below a consensus of $17.7M. The provider of "TV Everywhere" hardware/software solutions blames (what else?) soft service provider capex in North America and Western Europe. The news could have negative implications for Synacor (SYNC), whose fortunes are also heavily tied to TV Everywhere deployments. Envivio is now down 62% from April's $9 IPO price.
Array BioPharma (ARRY): FQ4 beats on a 9% Y/Y jump in total revenue. Net losses were pared significantly from the prior year period, as its top line was boosted by a jump in sales and its bottom line benefited from milestone payments from AMGN. Shares +6.6% AH
Groupon (GRPN): Q2 EPS of $0.08 beats by $0.05. Revenue of $568.3M (+45% Y/Y) misses by $4.8M. Expects Q3 revenue of $580M-$620M, in-line with $604.5M consensus. Expects Q3 operating income of $15M-$35M, below Q2's $46.5M. Shares -7.5% AH
Monster Beverage (MNST) +0.9% AH after announcing a new $250M stock buyback program. That boosts the energy drink maker's total available authorization to $500M, good for repurchasing 5.3% of shares at current levels. Monster fell last week on an earnings miss and AG probe
Summer Infant (SUMR): Q2 EPS of -$0.02 misses by $0.10. Revenue of $61.7M (+1.1% Y/Y) misses by $2M. Shares -19.2% AH.
Envivio (ENVI) -39.5% AH after warning it expects FQ2 revenue of $10M-$11M, well below a consensus of $17.7M. The provider of "TV Everywhere" hardware/software solutions blames (what else?) soft service provider capex in North America and Western Europe. The news could have negative implications for Synacor (SYNC), whose fortunes are also heavily tied to TV Everywhere deployments. Envivio is now down 62% from April's $9 IPO price.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
